2025-09-03 |
13D/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
3,826,692 |
10,000 |
|
|
|
2025-08-21 |
13D/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
3,059,630 |
10,000 |
|
|
|
2025-08-14 |
13G/A
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
3,812,773 |
166,879 |
|
|
|
2025-08-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
6,717,825 |
11,065,662 |
|
|
|
2025-08-14 |
13G/A
|
RVPH / Reviva Pharmaceuticals Holdings, Inc.
|
|
3,910,304 |
3,399,975 |
|
|
|
2025-08-14 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
1,900,000 |
1,500,000 |
|
|
|
2025-08-14 |
13G/A
|
CMPX / Compass Therapeutics, Inc.
|
|
11,052,632 |
13,496,208 |
|
|
|
2025-08-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
6,043,921 |
3,115,000 |
|
|
|
2025-07-30 |
13G
|
EPIX / ESSA Pharma Inc.
|
|
4,300,000 |
4,300,000 |
|
|
|
2025-07-22 |
13D/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
3,826,692 |
3,826,692 |
|
|
|
2025-07-09 |
13D/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
2,729,288 |
3,059,630 |
|
|
|
2025-06-12 |
13D
|
ITOS / iTeos Therapeutics, Inc.
|
|
3,826,692 |
3,826,692 |
|
|
|
2025-05-23 |
13D/A
|
SLRN / Acelyrin, Inc.
|
|
8,824,693 |
0 |
|
|
|
2025-05-19 |
13D/A
|
ALLK / Allakos Inc.
|
|
8,693,687 |
10,000 |
|
|
|
2025-05-15 |
13G/A
|
DTIL / Precision BioSciences, Inc.
|
|
623,332 |
673,332 |
|
|
|
2025-05-15 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
|
6,043,921 |
|
|
|
2025-05-15 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
8,216,960 |
8,223,612 |
|
|
|
2025-05-15 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
221,716 |
3,826,692 |
|
|
|
2025-05-15 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
2,454,797 |
|
|
|
2025-05-15 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
4,321,547 |
4,941,798 |
|
|
|
2025-05-15 |
13G/A
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
3,812,773 |
|
|
|
2025-05-15 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
7,811,760 |
6,717,825 |
|
|
|
2025-05-15 |
13G/A
|
EOLS / Evolus, Inc.
|
|
4,847,399 |
4,997,399 |
|
|
|
2025-05-15 |
13G/A
|
CMPX / Compass Therapeutics, Inc.
|
|
7,400,000 |
11,052,632 |
|
|
|
2025-05-15 |
13G/A
|
RVPH / Reviva Pharmaceuticals Holdings, Inc.
|
|
|
3,910,304 |
|
|
|
2025-05-15 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
1,900,000 |
|
|
|
2025-05-15 |
13G/A
|
DERM / Journey Medical Corporation
|
|
1,523,938 |
1,854,596 |
|
|
|
2025-05-15 |
13G/A
|
CYBN / Cybin Inc.
|
|
1,330,097 |
1,830,097 |
|
|
|
2025-05-15 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
3,158,265 |
|
|
|
2025-05-02 |
13D
|
HLVX / HilleVax, Inc.
|
|
|
4,920,000 |
|
|
|
2025-05-01 |
13G
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
3,200,000 |
|
|
|
2025-04-17 |
13D/A
|
ALLK / Allakos Inc.
|
|
8,693,687 |
8,693,687 |
|
|
|
2025-04-04 |
13G
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
2,178,609 |
|
|
|
2025-04-03 |
13D/A
|
ALLK / Allakos Inc.
|
|
8,693,440 |
8,693,687 |
|
|
|
2025-03-12 |
13D/A
|
SLRN / Acelyrin, Inc.
|
|
7,298,328 |
8,824,693 |
|
|
|
2025-03-10 |
13D
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
5,859,044 |
|
|
|
2025-03-04 |
13D/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
7,229,500 |
10,029,500 |
|
|
|
2025-02-27 |
13D/A
|
SLRN / Acelyrin, Inc.
|
|
5,298,328 |
7,298,328 |
|
|
|
2025-02-21 |
13D
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
2,729,288 |
|
|
|
2025-02-20 |
13D
|
SLRN / Acelyrin, Inc.
|
|
|
5,298,328 |
|
|
|
2025-02-14 |
13D
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
4,910,525 |
|
|
|
2025-02-14 |
13G/A
|
CYBN / Cybin Inc.
|
|
1,105,433 |
1,330,097 |
|
|
|
2025-02-14 |
13G/A
|
MNPR / Monopar Therapeutics Inc.
|
|
200,000 |
0 |
|
|
|
2025-02-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
2,407,800 |
221,716 |
|
|
|
2025-02-03 |
13D
|
ALLK / Allakos Inc.
|
|
|
8,693,440 |
|
|
|
2025-01-27 |
13G
|
NKTX / Nkarta, Inc.
|
|
|
7,014,100 |
|
|
|
2025-01-16 |
13G
|
CMPX / Compass Therapeutics, Inc.
|
|
|
7,400,000 |
|
|
|
2024-12-03 |
13G
|
CYBN / Cybin Inc.
|
|
|
1,105,433 |
|
|
|
2024-11-29 |
13G
|
DERM / Journey Medical Corporation
|
|
|
1,523,938 |
|
|
|
2024-11-14 |
13G
|
LIANY / LianBio - Depositary Receipt (Common Stock)
|
|
|
8,051,815 |
|
|
|
2024-11-14 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
4,321,547 |
|
|
|
2024-11-14 |
13G/A
|
DTIL / Precision BioSciences, Inc.
|
|
|
623,332 |
|
|
|
2024-11-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
|
1,330,879 |
|
|
|
2024-11-14 |
13G/A
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
600,000 |
|
|
|
2024-11-14 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
294,626 |
|
|
|
2024-11-14 |
13G/A
|
QNCX / Quince Therapeutics, Inc.
|
|
|
0 |
|
|
|
2024-11-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
|
8,216,960 |
|
|
|
2024-11-14 |
13G/A
|
BCAB / BioAtla, Inc.
|
|
|
874,076 |
|
|
|
2024-11-14 |
13G/A
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
766,940 |
|
|
|
2024-11-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
7,811,760 |
|
|
|
2024-11-14 |
13G/A
|
EOLS / Evolus, Inc.
|
|
|
4,847,399 |
|
|
|
2024-11-08 |
13D
|
EPIX / ESSA Pharma Inc.
|
|
|
4,300,000 |
|
|
|
2024-10-24 |
13G
|
MNPR / Monopar Therapeutics Inc.
|
|
|
200,000 |
|
|
|
2024-10-08 |
13D
|
KZR / Kezar Life Sciences, Inc.
|
|
|
7,200,000 |
|
|
|
2024-09-30 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
2,407,800 |
|
|
|
2024-09-18 |
13D
|
OMIC / Singular Genomics Systems, Inc.
|
|
|
372,000 |
|
|
|
2024-09-12 |
13D
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
7,229,500 |
|
|
|
2022-04-21 |
13G
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
18,796,125 |
|
|
|
2022-04-21 |
13G
|
US45791E1073 / INSPIRATO INC
|
|
|
2,432,600 |
|
|
|